YSPSL for Prevention of Delayed Graft Function Part B

NCT00298168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Diseases

Interventions

DRUG: YSPSL
DRUG: placebo
DRUG: YSPSL

Sponsor

Y's Therapeutics, Inc.